
Opinion|Videos|October 21, 2024
The Continued Evolution of Photodynamic Therapy
Author(s)Anthony M. Rossi, MD, FAAD, FACMS
Key Takeaways
- Advancements in photosensitizers and light delivery systems are expected to enhance PDT efficacy and reduce side effects in dermatology.
- Emerging studies focus on optimizing PDT for non-melanoma skin cancers, acne, and inflammatory skin diseases.
Anthony M. Rossi, MD, shares their perspective on the future evolution of photodynamic therapy (PDT) in dermatology practices and discusses emerging data or studies that will be crucial for dermatologists to stay informed about.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- In your opinion, how will the use of PDT continue to involve in dermatology practices?
- What new emerging PDT data or studies will be most important for dermatologists to familiarize themselves with?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants With Atopic Dermatitis Down to 3 Months
2
Teva Advances TEV-'408 Into Phase 2b for Vitiligo
3
Phase 1b Trial of FB102 Demonstrates Significant Facial Repigmentation and Sustained Vitiligo Response
4
GX-03 Phase 2 Program Expands to Full Atopic Dermatitis Spectrum
5















